Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingqiang Ren

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Genomics|November 16, 2018
Distinct signaling programs associated with progression of FGFR1 driven leukemia in a mouse model of stem cell leukemia lymphoma syndromeJeane Silva, Chang-Sheng Chang, Tianxiang Hu, et al.
Oncotarget|November 29, 2016
Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fateStefano Rossetti, MingQiang Ren, Nicolo Visconti, et al.
Oncology Reports|April 9, 2013
Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1Mingqiang Ren, Mei Hong, Gentao Liu, et al.
Frontiers in Medicine|October 1, 2025
Ultra-late relapse of acute promyelocytic leukemia 18 years after complete remission: a case report and literature reviewLu Gao, Yang An, Qian Li, et al.
Oncogene|January 26, 2018
The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinaseTianxiang Hu, Yating Chong, Haiyan Qin, et al.
Cancer Research|May 1, 2002
Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancerSilvia M Sirchia, Mingqiang Ren, Roberto Pili, et al.
Cancer Research|November 11, 2018
Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in MiceTianxiang Hu, Yating Chong, Sumin Lu, et al.
Leukemia|May 4, 2018
FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndromeTianxiang Hu, Qing Wu, Yating Chong, et al.
International Journal of Cancer|September 17, 2019
Critical individual roles of the BCR and FGFR1 kinase domains in BCR-FGFR1-driven stem cell leukemia/lymphoma syndromeYating Chong, Yun Liu, Sumin Lu, et al.
Case Reports in Genetics|December 12, 2018
Multifactorial Origin of Exertional Rhabdomyolysis, Recurrent Hematuria, and Episodic Pain in a Service Member with Sickle Cell TraitNyamkhishig Sambuughin, Mingqiang Ren, John F Capacchione, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Genomics|November 16, 2018
Distinct signaling programs associated with progression of FGFR1 driven leukemia in a mouse model of stem cell leukemia lymphoma syndromeJeane Silva, Chang-Sheng Chang, Tianxiang Hu, et al.
Oncotarget|November 29, 2016
Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fateStefano Rossetti, MingQiang Ren, Nicolo Visconti, et al.
Oncology Reports|April 9, 2013
Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1Mingqiang Ren, Mei Hong, Gentao Liu, et al.
Frontiers in Medicine|October 1, 2025
Ultra-late relapse of acute promyelocytic leukemia 18 years after complete remission: a case report and literature reviewLu Gao, Yang An, Qian Li, et al.
Oncogene|January 26, 2018
The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinaseTianxiang Hu, Yating Chong, Haiyan Qin, et al.
Cancer Research|May 1, 2002
Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancerSilvia M Sirchia, Mingqiang Ren, Roberto Pili, et al.
Cancer Research|November 11, 2018
Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in MiceTianxiang Hu, Yating Chong, Sumin Lu, et al.
Leukemia|May 4, 2018
FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndromeTianxiang Hu, Qing Wu, Yating Chong, et al.
International Journal of Cancer|September 17, 2019
Critical individual roles of the BCR and FGFR1 kinase domains in BCR-FGFR1-driven stem cell leukemia/lymphoma syndromeYating Chong, Yun Liu, Sumin Lu, et al.
Case Reports in Genetics|December 12, 2018
Multifactorial Origin of Exertional Rhabdomyolysis, Recurrent Hematuria, and Episodic Pain in a Service Member with Sickle Cell TraitNyamkhishig Sambuughin, Mingqiang Ren, John F Capacchione, et al.
Pageof 5